Search results
Results from the Health.Zone Content Network
In the case of HIV exposure, post-exposure prophylaxis (PEP) is a course of antiretroviral drugs which reduces the risk of seroconversion after events with high risk of exposure to HIV (e.g., unprotected anal or vaginal sex, needlestick injuries, or sharing needles ). [21] The CDC recommends PEP for any HIV-negative person who has recently been ...
Hepatitis B is a viral infection caused by the hepatitis B virus (HBV). It can cause liver inflammation (hepatitis), leading to signs and symptoms that can range from mild illness to severe liver ...
Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV – United States, 2016). (2018). https://stacks.cdc.gov ...
Post-exposure prophylaxis (PEP). Antiretroviral drugs don’t kill viruses. But a short course of these HIV medications, taken within 72 hours of your exposure to the virus, may keep it from ...
PEP Side Effects. Side effects of PEP include: Upset stomach. Fatigue. Headache. Diarrhea. Insomnia. Rarely, the drugs can cause serious health issues, including liver problems.
HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen. It is extracted from the Cohn fraction II. During the process, viruses are deactivated, and in the final steps, solvents used in the preparation are removed. The preparation is tested for absence of HIV, HCV, herpes virus, and reovirus.
A hepatitis B titer test measures antibodies in your blood to see if you’re immune either due to vaccination or previous infection. Hepatitis B is a viral infection that targets your liver. It ...
Unless the source is known to be negative for HBV, HCV, and HIV, post-exposure prophylaxis (PEP) should be initiated, ideally within one hour of the injury. Hepatitis B. The risk of hepatitis B (e antigen positive) seroconversion is estimated at 37–62%, significantly more than other blood borne pathogens.